Summary
- Profile Type
- Technology offer
- POD Reference
- TODE20250401004
- Term of Validity
- 1 April 2025 - 1 April 2026
- Company's Country
- Germany
- Type of partnership
- Commercial agreement with technical assistance
- Targeted Countries
- All countries
Contact the EEN partner nearest to you for more information.
Find my local partner
General information
- Short Summary
- A German university offers a method to diagnose in vitro polyneuropathies (PNPs) in patients with sensory and motor impairment as well as to stratify PNP patients. In addition the invention relates to a method determining therapeutic treatment. The invention is lab-tested.Providers of diagnostic products are sought for licensing agreements to produce and sell the invention.
- Full Description
-
Specifically, polyneuropathies (PNPs) denote diseases of multiple peripheral nerves and range among the most common neurological diseases, affecting at least 4% of the middle-age and elderly population. Patients affected by PNPs suffer from progressive sensory and motor impairment and an often painful life-long aggravating disease with an enormous socio-economic impact. The underlying causes of PNPs are very diverse and comprise diabetic, toxic inflammatory/immune-mediated, hereditary, metabolic and vitamin deficiency. Despite comprehensive diagnostic work-up, the underlying cause of PNPs is unclear in many patients (20-30 %). Biopsy of the sensory sural nerve at the lateral ankle is often the final diagnostic step to assess specific causes in human PNP patients, but even biopsy does not lead to a diagnosis in many patients. This could be due to an insufficient depth of analysis of this tissue. Fully exploiting this precious biomaterial for mechanistic understanding and diagnostic potential is especially important to detect treatable causes such as immune mediated neuropathies, which account for up to 10% of the PNPs and are treatable.
A German university is now able to present an invention that relates to an in vitro method for diagnosing polyneuropathy (PNP) in a subject as well as a method of stratifying a subject with polyneuropathy (PNP). Further, the present invention relates to a method for determining therapeutic treatment of PNP in a subject as well as to the use of any method of the present invention for determining a treatment regime for a subject suffering from PNP. Finally, patients could be categorized into patient clusters identified solely by single cell transcriptomics which hinted towards mechanistic patterning of patients. The inventors thus provide a single cell atlas for the human peripheral nerve in health and PNPs and discover potential for an unbiased diagnostic classification of PNPs. - Advantages and Innovations
- The inventors identified and spatially validated novel and partially human-specific markers. By combining single nuclei and spatial transcriptomics of human sural nerve biopsies, the inventors provide the first large-scale single cell atlas of human peripheral nerves. Skin biopsy, or a biopsy from any other tissue containing peripheral nerves or liquids, such as blood, CSF, or cellular material comprising nerves, or meningeal biopsies, or cerebrospinal fluid are planned for the future. The present invention enables that PNP patients were categorized into clusters identified by single cell transcriptomics with specific phenotypes beyond existing clinical classification.
- Stage of Development
- Lab tested
- Sustainable Development Goals
- Goal 3: Good Health and Well-being
- IPR status
- IPR applied but not yet granted
- IPR notes
- Patent application filed in Europe
Partner Sought
- Expected Role of a Partner
-
Type and Role of Partner Sought: The university offers license agreements
Type of partner sought: Provider of diagnostic products
Role of partner: Produce and sell the invention - Type and Size of Partner
- SME 50 - 249
- SME 11-49
- Big company
- Type of partnership
- Commercial agreement with technical assistance
Dissemination
- Technology keywords
- 06001012 - Medical Research
- 06001005 - Diagnostics, Diagnosis
- Market keywords
- 05001002 - In-vitro diagnostics
- 05003001 - Therapeutic services
- Sector Groups Involved
- Health
- Targeted countries
- Afghanistan
- Aland Islands
- Albania
- Algeria
- American Samoa
- Andorra
- Angola
- Anguilla
- Antarctica
- Antigua and Barbuda
- Argentina
- Armenia
- Aruba
- Australia
- Austria
- Azerbaijan
- Bahamas
- Bahrain
- Bangladesh
- Barbados
- Belarus
- Belgium
- Belize
- Benin
- Bermuda
- Bhutan
- Bolivia
- Bonaire, Saint Eustatius and Saba
- Bosnia and Herzegovina
- Botswana
- Bouvet Island
- Brazil
- British Indian Ocean Territory
- British Virgin Islands
- Brunei
- Bulgaria
- Burkina Faso
- Burundi
- Cabo Verde
- Cambodia
- Cameroon
- Canada
- Cayman Islands
- Central African Republic
- Chad
- Chile
- China
- Christmas Island
- Cocos Islands
- Colombia
- Comoros
- Cook Islands
- Costa Rica
- Croatia
- Cuba
- Curacao
- Cyprus
- Czechia
- Democratic Republic of the Congo
- Denmark
- Djibouti
- Dominica
- Dominican Republic
- Ecuador
- Egypt
- El Salvador
- Equatorial Guinea
- Eritrea
- Estonia
- Eswatini
- Ethiopia
- Falkland Islands
- Faroe Islands
- Fiji
- Finland
- France
- French Guiana
- French Polynesia
- French Southern Territories
- Gabon
- Gambia
- Georgia
- Germany
- Ghana
- Gibraltar
- Greece
- Greenland
- Grenada
- Guadeloupe
- Guam
- Guatemala
- Guernsey
- Guinea
- Guinea-Bissau
- Guyana
- Haiti
- Heard Island and McDonald Islands
- Honduras
- Hong Kong
- Hungary
- Iceland
- India
- Indonesia
- Iran
- Iraq
- Ireland
- Isle of Man
- Israel
- Italy
- Ivory Coast
- Jamaica
- Japan
- Jersey
- Jordan
- Kazakhstan
- Kenya
- Kiribati
- Kosovo
- Kuwait
- Kyrgyzstan
- Laos
- Latvia
- Lebanon
- Lesotho
- Liberia
- Libya
- Liechtenstein
- Lithuania
- Luxembourg
- Macao
- Madagascar
- Malawi
- Malaysia
- Maldives
- Mali
- Malta
- Marshall Islands
- Martinique
- Mauritania
- Mauritius
- Mayotte
- Mexico
- Micronesia
- Moldova
- Monaco
- Mongolia
- Montenegro
- Montserrat
- Morocco
- Mozambique
- Myanmar
- Namibia
- Nauru
- Nepal
- Netherlands
- Netherlands Antilles
- New Caledonia
- New Zealand
- Nicaragua
- Niger
- Nigeria
- Niue
- Norfolk Island
- North Korea
- North Macedonia
- Northern Mariana Islands
- Norway
- Oman
- Pakistan
- Palau
- Palestinian Territory
- Panama
- Papua New Guinea
- Paraguay
- Peru
- Philippines
- Pitcairn
- Poland
- Portugal
- Puerto Rico
- Qatar
- Republic of the Congo
- Reunion
- Romania
- Russia
- Rwanda
- Saint Barthelemy
- Saint Helena
- Saint Kitts and Nevis
- Saint Lucia
- Saint Martin
- Saint Pierre and Miquelon
- Saint Vincent and the Grenadines
- Samoa
- San Marino
- Sao Tome and Principe
- Saudi Arabia
- Senegal
- Serbia
- Seychelles
- Sierra Leone
- Singapore
- Sint Maarten
- Slovakia
- Slovenia
- Solomon Islands
- Somalia
- South Africa
- South Georgia and the South Sandwich Islands
- South Korea
- South Sudan
- Spain
- Sri Lanka
- Sudan
- Suriname
- Svalbard and Jan Mayen
- Sweden
- Switzerland
- Syria
- Taiwan
- Tajikistan
- Tanzania
- Thailand
- Timor Leste
- Togo
- Tokelau
- Tonga
- Trinidad and Tobago
- Tunisia
- Turkey
- Turkmenistan
- Turks and Caicos Islands
- Tuvalu
- U.S. Virgin Islands
- Uganda
- Ukraine
- United Arab Emirates
- United Kingdom
- United States
- United States Minor Outlying Islands
- Uruguay
- Uzbekistan
- Vanuatu
- Vatican
- Venezuela
- Vietnam
- Wallis and Futuna
- Western Sahara
- Yemen
- Zambia
- Zimbabwe